Team:LMU-Munich/Application

From 2012.igem.org

(Difference between revisions)
Line 32: Line 32:
<br>
<br>
== '''Kumamolisin'''-'''Sporo'''beads ==
== '''Kumamolisin'''-'''Sporo'''beads ==
-
'''the solution for carefree enjoyment of everyday meals for Coeliac disease!'''
+
'''the solution for carefree enjoyment of everyday meals for Celiac sufferers!'''
<br>
<br>
[[File:LMU-Munich-spore-Gluten_cutting.jpg|left]]
[[File:LMU-Munich-spore-Gluten_cutting.jpg|left]]
<p align="justify">
<p align="justify">
-
World-wide, one out of [http://www.enriquecastro.net/index.php/term/,9da4ab975b545ba0ae53646c58a5a265aa5d535892a89b979fa4b1a49297a261a260555c5a.xhtml 3350] people cannot eat meals that contain wheat products or other foods with traces of gluten. This disease is known as Coeliac disease. Kumamolisin is an [http://partsregistry.org/wiki/index.php?title=Part:BBa_K590087 enzyme] that cleaves peptides and was produced by the iGEM-Team from the University of [https://2011.igem.org/Team:Washington Washington] last year. The substrate includes a specific sequence of amino acids, which causes Coeliac disease in sensitive people when they consume food containing gluten. Our beads could carry Kumamolisin as a secure vehicle for the passage to the stomach, so that the enzyme can work properly where it is needed. The [https://2012.igem.org/Team:LMU-Munich/Germination_Stop <b>Germination</b>STOP] we integrated in our spores would prevent outgrowth and ensure a correct dosage. This project is a pharmaceutical application and therefore would have to fulfill the legal requirements for pharmaceuticals. This includes several verification steps of non-toxicity and efficacy (for more information see [https://2012.igem.org/Team:LMU-Munich/Project_Safety release for application]
+
World-wide, one out of [http://www.enriquecastro.net/index.php/term/,9da4ab975b545ba0ae53646c58a5a265aa5d535892a89b979fa4b1a49297a261a260555c5a.xhtml 3350] people cannot eat meals that contain wheat products or other foods with traces of gluten. This disease is known as Celiac disease. Kumamolisin is an [http://partsregistry.org/wiki/index.php?title=Part:BBa_K590087 enzyme] that cleaves peptides and was produced by the iGEM-Team from the [https://2011.igem.org/Team:Washington University of Washington] last year. The substrate includes a specific sequence of amino acids, which causes Celiac disease in sensitive people when they consume food containing gluten. Our beads could carry Kumamolisin as a secure vehicle for the passage to the stomach, so that the enzyme can work properly where it is needed. The [https://2012.igem.org/Team:LMU-Munich/Germination_Stop <b>Germination</b>STOP] we integrated in our spores would prevent outgrowth and ensure a correct dosage. This project is a pharmaceutical application and therefore would have to fulfill the legal requirements for pharmaceuticals. This includes several verification steps of non-toxicity and efficacy (for more information see [https://2012.igem.org/Team:LMU-Munich/Project_Safety release for application].
</p>
</p>

Revision as of 01:50, 27 September 2012

iGEM Ludwig-Maximilians-Universität München Beadzillus

Team-LMU Photo2.jpg

The LMU-Munich team is exuberantly happy about the great success at the World Championship Jamboree in Boston. Our project Beadzillus finished 4th and won the prize for the "Best Wiki" (with Slovenia) and "Best New Application Project".

IGEM HQ LMU prize.jpg

[ more news ]

Sporenfreunde